SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth

Cancer Research

Volumn 63, Issue 14, 2003, Pages 3919-3922

  Filleur, Stéphanie ^a   Courtin, Aurélie ^a   Ait Si Ali, Slimane ^a   Guglielmi, Julien ^b   Merle, Carole ^a   Harel Bellan, Annick ^a   Clézardin, Philippe ^b   Cabon, Florence ^a,c  

^a CNRS UPR 9079 Oncogenese Differenciation et Transduction du Signal   (France)

^b INSERM   (France)

^c INSTITUT ANDRÉ LWOFF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; DOUBLE STRANDED RNA; LUCIFERASE; THROMBOSPONDIN 1; VASCULOTROPIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL SECRETION; FIBROSARCOMA; GROWTH RATE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; TUMOR CELL; TUMOR GROWTH; TUMOR RESISTANCE; TUMOR VASCULARIZATION;

EID: 0042173218     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Rastinejad, F., Polverini, P. J., and Bouck, N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell, 56:345-355, 1989.
2. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.). 390: 404-407, 1997.
3. Filleur, S., Volpert, O. V., Degeorges, A., Voland, C., Reiher. F., Clezardin, P., Bouck, N., and Cabon. F. In vivo mechanisms by which tumors producing thrombospondin 1 bypass its inhibitory effects. Genes Dev., 15: 1373-1382, 2001.
4. Viloria-Petit, A., Crombet, T., Jothy, S., Hicklin, D., Bohlen, P., Schlaeppi, J. M., Rak, J., and Kerbel, R. S. Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis. Cancer Res., 61: 5090-5101, 2001.
5. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
6. Shi, Y. Mammalian RNAi for the masses. Trends Genet., 19: 9-12, 2003.
7. McManus, M. T., and Sharp, P. A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet., 3: 737-747, 2002.
8. Brummelkamp, T. R., Bemards, R., and Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science (Wash. DC), 296: 550-553, 2002.
9. Brummelkamp, T. R., Bemards, R., and Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell. 2: 243-247, 2002.
10. Lewis, D. L., Hagstrom, J. E., Loomis, A. G., Wolff. J. A,. and Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet., 32: 107-108, 2002.
11. McCaffrey, A. P., Meuse, L., Pham, T. T., Conklin, D. S., Hannon, G. J., and Kay, M. A. RNA interference in adult mice. Nature (Lond.). 418: 38-39, 2002.
12. Mettouchi, A., Cabon, F., Montreau, N., Vernier, P., Mercier, G.,Blangy, D., Tricoire, H., Vigier, P., and Binetruy, B. SPARC and thrombospondin genes are repressed by the c-jun oncogene in rat embryo fibroblasts, EMBO J., 13: 5668-5678, 1994.
13. Garber. K. Angiogenesis inhibitors suffer new setback. Nat. Biotechnol., 20: 1067-1068, 2002.
14. Kerbel, R., and Folkman, J. Clinical translation of angiogenesis inhibitors. Nat. Rev. Cancer. 2: 727-739, 2002.
15. O'Reilly, M. S. Targeting multiple biological pathways as a strategy to improve the treatment of cancer, Clin. Cancer Res., 8: 3309-3310, 2002.
16. Li, M., Ye, C., Feng, C., Riedel, F., Liu, X., Zeng, Q., and Grandis. J. R. Enhanced antiangiogenic therapy of squamous cell carcinoma by combined endostatin and epidermal growth factor receptor-antisense therapy. Clin. Cancer Res., 8: 3570-3578. 2002.
17. Martinez. L. A., Naguibneva, I., Lehrmann, H., Vervisch, A., Tchenio, T., Lozano, G., and Harel-Bellan, A. Synthetic small inhibiting RNAs: efficient tools to inactivate oncogenic mutations and restore p53 pathways. Proc. Natl. Acad. Sci. USA, 99: 14849-14854, 2002.